MEDTRONIC PLC's ticker is MDT and the CUSIP is G5960L103. A total of 1,208 filers reported holding MEDTRONIC PLC in Q3 2016. The put-call ratio across all filers is 1.28 and the average weighting 0.6%.
About MEDTRONIC PLC
Medtronic PLC is a global leader in medical technology, offering a wide range of products and services to improve patient outcomes. The company's mission is to alleviate pain, restore health, and extend life for millions of people around the world.
Medtronic's product portfolio includes devices for the treatment of chronic diseases such as diabetes, heart disease, and neurological disorders. The company's innovative technologies have helped to revolutionize the healthcare industry, providing patients with better treatment options and improving their quality of life.
One of Medtronic's most significant achievements is the development of the world's first implantable pacemaker in 1958. Since then, the company has continued to innovate and expand its product offerings, including the development of the world's smallest pacemaker, the Micra Transcatheter Pacing System.
Medtronic's commitment to innovation and patient care has earned the company numerous awards and recognitions, including being named one of the World's Most Admired Companies by Fortune Magazine.
In addition to its product offerings, Medtronic is also committed to giving back to the community through its philanthropic efforts. The company's Medtronic Foundation supports initiatives that improve access to healthcare and education in underserved communities around the world.
Overall, Medtronic PLC is a company that is dedicated to improving the lives of patients through innovative medical technologies and a commitment to social responsibility.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,553,234 | +10.9% | 40,332 | +1.5% | 0.06% | +3.8% |
| Q1 2023 | $3,204,578 | +14.5% | 39,749 | +10.3% | 0.05% | +10.4% |
| Q4 2022 | $2,799,954 | -11.7% | 36,026 | -8.2% | 0.05% | -22.6% |
| Q3 2022 | $3,170,000 | -24.5% | 39,253 | -16.1% | 0.06% | -18.4% |
| Q2 2022 | $4,198,000 | -18.9% | 46,779 | +0.3% | 0.08% | -3.8% |
| Q1 2022 | $5,176,000 | +10.5% | 46,654 | +3.1% | 0.08% | +14.5% |
| Q4 2021 | $4,683,000 | -16.6% | 45,269 | +1.1% | 0.07% | -23.3% |
| Q3 2021 | $5,614,000 | -1.1% | 44,785 | -2.1% | 0.09% | -1.1% |
| Q2 2021 | $5,679,000 | +4.6% | 45,747 | -0.4% | 0.09% | -1.1% |
| Q1 2021 | $5,428,000 | +1.2% | 45,950 | +0.4% | 0.09% | -6.1% |
| Q4 2020 | $5,361,000 | +4.0% | 45,763 | -7.8% | 0.10% | -4.9% |
| Q3 2020 | $5,155,000 | +13.3% | 49,608 | +0.0% | 0.10% | +5.1% |
| Q2 2020 | $4,548,000 | -3.3% | 49,591 | -4.9% | 0.10% | -14.0% |
| Q1 2020 | $4,703,000 | -22.2% | 52,147 | -2.1% | 0.11% | +2.7% |
| Q4 2019 | $6,045,000 | +9.7% | 53,282 | +5.0% | 0.11% | +2.8% |
| Q3 2019 | $5,510,000 | +12.2% | 50,728 | +0.6% | 0.11% | +10.2% |
| Q2 2019 | $4,911,000 | +16.5% | 50,423 | +8.9% | 0.10% | +15.3% |
| Q1 2019 | $4,217,000 | +0.3% | 46,300 | +0.2% | 0.08% | -11.5% |
| Q4 2018 | $4,204,000 | -6.5% | 46,215 | +1.2% | 0.10% | +6.7% |
| Q3 2018 | $4,494,000 | +12.9% | 45,686 | -1.7% | 0.09% | +7.1% |
| Q2 2018 | $3,980,000 | +14.0% | 46,493 | +6.9% | 0.08% | +12.0% |
| Q1 2018 | $3,490,000 | -2.4% | 43,503 | -1.7% | 0.08% | +4.2% |
| Q4 2017 | $3,574,000 | +0.7% | 44,263 | -3.0% | 0.07% | -4.0% |
| Q3 2017 | $3,548,000 | -13.1% | 45,628 | -0.8% | 0.08% | -19.4% |
| Q2 2017 | $4,082,000 | +14.3% | 45,991 | +3.8% | 0.09% | +9.4% |
| Q1 2017 | $3,571,000 | +10.7% | 44,325 | -2.1% | 0.08% | +7.6% |
| Q4 2016 | $3,226,000 | -21.6% | 45,284 | -4.9% | 0.08% | -23.3% |
| Q3 2016 | $4,113,000 | +3.7% | 47,602 | +4.1% | 0.10% | +2.0% |
| Q2 2016 | $3,968,000 | +21.3% | 45,730 | +4.8% | 0.10% | +17.4% |
| Q1 2016 | $3,272,000 | -32.2% | 43,622 | -30.4% | 0.09% | -34.8% |
| Q4 2015 | $4,824,000 | +35.4% | 62,710 | +17.8% | 0.13% | +26.9% |
| Q3 2015 | $3,564,000 | -20.2% | 53,248 | -11.6% | 0.10% | -14.0% |
| Q2 2015 | $4,464,000 | -73.5% | 60,248 | -72.1% | 0.12% | -65.5% |
| Q1 2015 | $16,835,000 | – | 215,858 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Envoi LLC | 300,026 | $24,227,099 | 81.15% |
| Financial Perspectives, Inc | 227,044 | $18,333,831 | 10.28% |
| Glaxis Capital Management, LLC | 8,000 | $646,000 | 9.34% |
| ALTRINSIC GLOBAL ADVISORS LLC | 2,423,550 | $195,702,000 | 9.01% |
| INTREPID FAMILY OFFICE LLC | 33,000 | $2,665,000 | 8.06% |
| SECTOR GAMMA AS | 269,957 | $21,799,000 | 5.62% |
| XXEC, Inc. | 70,356 | $5,681,000 | 4.89% |
| CLARK ESTATES INC/NY | 265,000 | $21,399,000 | 4.73% |
| Saratoga Research & Investment Management | 1,024,064 | $82,693,000 | 4.37% |
| Hall Private Wealth Advisors | 84,091 | $6,790,000 | 3.91% |